Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders

Croatian Medical Journal

Volumn 54, Issue 5, 2013, Pages 453-459

  Topić, Radmila ^a   Miličić, Davor ^a   Štimac, Zoran ^a   Lončar, Mladen ^a   Velagić, Vedran ^a   Marčinko, Darko ^a   Jakovljević, Miro ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BONE DISEASE; CARCINOMA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; METABOLIC SYNDROME X; RECURRENT DISEASE; THYROID DISEASE; UNIVERSITY HOSPITAL;

ADULT; AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84888425541     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2013.54.453     Document Type: Article

References (19)

1. Jakovljevic M. Psychopharmacotherapy and comorbidity: Conceptual and epistemiological issues, dilemmas and controversies. Psychiatr Danub. 2009;21:333-40. Medline:19794352
2. Jakovljevic M, Crncevic Ž. Comorbidity as an epistemiological challenge to modern psychiatry. Dialogues in Philosophy. Mental and Neuro Sciences. 2012;5:1-13.
3. S teptoe A. Depression and the development of coronary heart disease. In: Steptoe A, editor. Depression and physical illness. Caambridge: Cambridge University Press; 2007. p. 53-86.
4. Kerber KB, Rubenfire M. Depression and cardiovascular diseases. In: Riba M, Wulsin L, Rubenfire M, editors. psychiatry and heart disease - the mind, brain and heart. Hoboken: John Wiley & Sons; 2012. p. 18-33.
5. C apuron L, Shaoyong SU, Miller AH, Bremner JD, Goldberg J, Vogt GJ, et al. Depressive symptoms and metabolic syndrome: Is inflammation the underlying link? Biol Psychiatry. 2008;64:896-900. Medline:18597739 doi:10.1016/j.biopsych.2008.05.019
6. Jakovljevic M, Crncevic Z, Ljubicic Dj, Babic D, Topic R, Saric M. Mental disorders and metabolic syndrome: A fatamorgana or warning reality? Psychiatr Danub. 2007;19:76-86. Medline:17603420
7. Zahn D, Petrak F, Uhl I, Juckel I, Neubauer H, Haegele AK, et al. New pathways of increased cardiovascular risk in depression: A pilot study on the association of high-sensitivity C-reactive protein with pro-atherosclerotic marker sin patients with depression. J Affect Disord. 2013;146:420-5. Medline:22999070 doi:10.1016/j. jad.2012.07.030
8. Vogelzangs N, Duivis HE, Beekman ATF, Kluft C, Neuteboom J, Hoogendijk W, et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry. 2012;2:e79. Medline:22832816 doi:10.1038/tp.2012.8
9. O reski I, Jakovljevic M, Aukst-Margetic B, Crncevic-Orlic Z, Vuksan-Cusa B. Comorbidity and multimorbidity in patients with shizophrenia and bipolar disorder: Similarities and differencies. Psychiatr Danub. 2012;24:80-5. Medline:22447090
10. Kahl KG, Greggersen W, Schweiger U, Cordes J, Balijepalli C, Loesch C, et al. Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci. 2012;262:313-20. Medline:22183567 doi:10.1007/s00406-011-0277-4
11. Demirci H, Cinar Y, Bilgel N. Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey. Bulletin of Clinical Psychopharmacology. 2011;21:49-57. doi:10.5350/KPBBCP201121108
12. Pan A, Keum NN, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between deoresion and metabolic syndrome - a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012;35:1171-80. Medline:22517938 doi:10.2337/dc11-2055
13. N abe K, Nomura K, Ikeda H, Honjo S, Wada Y, Kinura T, et al. Depression is a component of the metabolic syndrome. Medical Hypotheses and Research. 2008;4:79-83.
14. H artley TA, Knox SS, Fekedulegn D, Barbosa-Leiker C, Violanti JM, Andrew ME, et al. Association between depressive symptoms and metabolic syndrome in police offers: Results from two crosssectional studies. Journal of Environmental and Public Health. 2012:2012. Medline:22315628 doi:10.1155/2012/861219
15. Morris AA, Zhao L, Ahmed Y, Stoyanova N, De Staercke C, Hooper WC, et al. Association between depression and inflammation - differences by race and sex: the META-Health study. Psychosom Med. 2011;73:462-8. Medline:21715300 doi:10.1097/ PSY.0b013e318222379c
16. C opeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: A prospective analysis. Biol Psychiatry. 2012;71:15-21. Medline:22047718 doi:10.1016/j.biopsych.2011.09.023
17. Huffman FG, Perez Gomez G, Zarini GG. Metabolic syndrome and high-sensitivity c-reactive protein in Cubans. Ethn Dis. 2009;19:115-20. Medline:19537220
18. Ma Y, Chiriboga DE, Pagoto SL, Rosal MC, Li W, Merriam PA, et al. Association between depression and C-reactive protein. Cardiol Res Pract. 2010;2011:286509. Medline:21234098
19. Yudkin JS, Kumari M, Humphries SE, Muhamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-14. Medline:10657556 doi:10.1016/ S0021-9150(99)00463-3